 (7 Neurol Neurosurg Psychiatry 1995;58:85-87) 
Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune disease, often associated with small cell lung cancer (SCLC), in which antibodies are directed against voltage-gated calcium channels (VGCCs) situated on the presynaptic nerve terminal.' The VGCCs may be classified by their electrophysiological characteristics into at least four subtypes (T, L, N, and P).2 3 We have previously detected antibodies to N-type VGCCs in a proportion of patients with LEMS using co-conotoxin GVIA (a-CgTx), purified from the fish hunting cone snail (Conus geographus), which blocks neuronal Ntype VGCCs.4 Similar assays have been described by Sher and colleagues5 and Lennon and Lambert.6 In our series, however, less than 50% of serum samples were clearly positive and some autoimmune disease controls gave equivocal results. 4 counting. All steps were performed at 4°C. The specific binding was calculated from the total 125I-co-CmTx precipitated minus the non-specific binding determined by performing the assay in the presence of excess unlabelled co-CmTx (100 nM). Serum samples were available from 66 patients with typical clinical and EMG features of LEMS. The EMG criteria comprised (a) a reduced amplitude of the resting compound muscle action potential (CMAP) in abductor digiti minimi (<8-5 mV) and (b) an increment in CMAP amplitude after 15 seconds maximum voluntary contraction of the muscle >100% of resting CMAP. 14 Twenty two patients had histologically proved small cell lung carcinoma (SCLC), and 29 patients had been followed up for more than five years without signs of SCLC (no cancer detected, NCD). The SCLC status of the remaining 15 patients, followed up for less than five years, was regarded as uncertain (SU). The 50 controls were 10 healthy subjects, and 10 patients each with either SCLC without neurological symptoms, myasthenia gravis, other neurological diseases, or rheumatoid arthritis/systemic lupus erythematosus.
125I-*-CmTx binding sites were retested using 2-5 p1. Results are expressed as pmol specific "251--GCmTx binding sites precipitated/litre of serum after subtraction of non-specific binding (see methods).
Fifty six of 66 LEMS samples (85%) were positive for the presence of VGCC antibodies, defined as a titre >40 pM (3SD above the mean for the healthy controls; figure (B), dotted line). The mean titres in the three clinical groups (SCLC, NCD, SU) did not differ significantly. The proportions of patients positive for antibody in the three groups were 90%, 76%, and 93% respectively. The antibody titres for all disease control samples (n = 40) were negative (<40 pM).
Results
The figure (A) shows quantitative precipitation of 251I-GCmTx-VGCC from digitonin extracted cerebellum from two patients with LEMS. A healthy control serum showed nonspecific binding only. To detennine antibody titres routinely, 10 pl of serum was tested first and those samples precipitating >10 fnol of 
Discussion
In our previous study4 we showed that antibodies could be detected using 251I-wC-CgTx to label N-type VGCCs, but this assay yielded positive titres in only 44% of patients with LEMS. The role of anti-N-type VGCC antibodies is uncertain, but they might contribute to the disturbance of the autonomic nervous system in LEMS as N-type VGCCs are concerned in transmitter release from some autonomic nerves. '5 The use of P-type VGCCs should provide a better diagnostic assay because this channel subtype is responsible for neurotransmitter release at the mammalian neuromuscular junction.8 Also LEMS IgG blocked potassium stimulated Ca2+ flux in a human SCLC cell line, leading to the suggestion that P-type VGCCs might be the principal target for LEMS IgG.9 10 Moreover, similar lines have been shown to express mRNA for P-type VGCCs.7 In our present study we have detected positive titres in 85% of 66 patients with LEMS, using 251_--GCmTx. Although _-CgTx also binds to cerebellar extracts, less than 25% of the serum samples were positive when '25I-CgTx was substituted for "25I-CmTx (unpublished Adie3 described 19 patients, 13 with absent tendon reflexes, and noted 44 reported cases of tonic pupil. In an exemplary clinical essay, he outlined four incomplete forms (the last would not now be accepted). "1. The complete form-typical tonic pupil and absence of reflexes.
2. Incomplete forms: a) tonic pupil alone; b) atypical phase of the tonic pupil alone (iridoplegia"; intemal opthalmoplegia"); c) atypical phases of the tonic pupil with absent reflexes; d) absent reflexes alone." Adie did not claim originality, recognising descriptions from 1902. Holmes's work is not acknowledged in Adie's Brain paper. Adie commented on the past misconstrued attribution to syphilis: "A perversion of nervous activity" of the vegetative nervous system was, he thought, the cause.
It was the London ophthalmologist, James Ware (1756-1815), however, who furnished one of the earliest depictions in 1813. 6 J M S PEARCE
